Sales decline 26.83% to Rs 14.13 crore
Net Loss of Parabolic Drugs reported to Rs 43.12 crore in the quarter ended September 2016 as against net loss of Rs 101.86 crore during the previous quarter ended September 2015. Sales declined 26.83% to Rs 14.13 crore in the quarter ended September 2016 as against Rs 19.31 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales14.1319.31 -27 OPM %0.99-301.55 -PBDT-28.18-84.78 67 PBT-41.57-101.86 59 NP-43.12-101.86 58Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
